News for Syros Pharmaceuticals Stock (SYRS)

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/25/24

The Schall Law Firm Encourages Shareholders With Losses In Syros Pharmaceuticals, Inc. To Join An Inquiry For Securities Law Violations

Accesswire • 09/24/24

Syros Pharmaceuticals Inc Is Being Looked Into For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/23/24

The Schall Law Firm Encourages Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 09/22/24

Investors Are Urged To Join The Schall Law Firm In A Securities Fraud Inquiry Into Syros Pharmaceuticals Inc

Accesswire • 09/21/24

Syros Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Wants Shareholders To Help With An Investigation

Accesswire • 09/20/24

The Schall Law Firm Has Launched An Inquiry Into Syros Pharmaceuticals Inc's Possible Securities Fraud And Investors Are Urged To Join

Accesswire • 09/19/24

Syros Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Reach Out

Accesswire • 09/18/24

Investors With Losses In Syros Pharmaceuticals Inc Can Join The Schall Law Firm's Securities Fraud Inquiry

Accesswire • 09/17/24

The Schall Law Firm Is Looking Into Syros Pharmaceuticals, Inc. For Possible Securities Related Infractions And Affected Shareholders Are Urged To Reach Out

Accesswire • 09/16/24

Syros Pharmaceuticals Inc May Have Violated Securities Laws And The Schall Law Firm Wants Investors To Join An Inquiry

Accesswire • 09/15/24

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders Are Urged To Reach Out

Accesswire • 09/14/24

Investors Are Invited By The Schall Law Firm To Join An Inquiry Into Possible Securities Law Violations By Syros Pharmaceuticals Inc

Accesswire • 09/13/24

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders With Losses Can Reach Out

Accesswire • 09/12/24

Syros Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Securities Law Violations And The Firm Seeks Investor Participation

Accesswire • 09/11/24

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders Are Encouraged To Reach Out

Accesswire • 09/10/24

Syros Pharmaceuticals Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Assist The Schall Law Firm

Accesswire • 09/09/24

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Shareholders to Connect

Accesswire • 09/08/24

The Schall Law Firm Is Looking Into Whether Securities Fraud Was Committed By Syros Pharmaceuticals, Inc. And Shareholders Can Reach Out

Accesswire • 09/07/24

Syros Pharmaceuticals Inc May Have Violated Securities Laws And Investors Are Invited To Join The Schall Law Firm In An Inquiry

Accesswire • 09/06/24

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Stockholders to Connect

Accesswire • 09/06/24

The Schall Law Firm Seeks Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc.'s Potential Securities Related Infractions

Accesswire • 09/05/24

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Investors to Connect

Accesswire • 09/05/24

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Business Wire • 09/04/24

An Inquiry Has Been Launched Into Syros Pharmaceuticals Inc.'s Potential Securities Law Violations And Stockholders Can Lend A Hand To The Schall Law Firm

Accesswire • 09/04/24